Archive for the ‘Health News’ category

Immediate biopsy unnecessary for some breast lumps

December 4th, 2009           1 views

SOURCES: American Journal of Roentgenology, December 2009.

NEW YORK (Reuters Health) – For breast lumps that can be felt with the fingers but look benign on ultrasound, an immediate biopsy may not be needed, particularly for some young women, researchers report.

Instead, the researchers write in the December issue of the American Journal of Roentgenology, a checkup six months later would be fine for such “palpable lesions.”

“Many palpable lumps that are solid (not a fluid filled cyst) on ultrasound undergo either needle or surgical biopsy, even when they appear benign on imaging,” Dr. Jennifer A. Harvey, who led the study, noted in an email to Reuters Health.

She and colleagues at the University of Virginia, Charlottesville, evaluated 375 “palpable lesions” detected in 320 women over six and a half years.

After an average follow-up period of almost three years, just one of the lumps turned out to be cancer – that is, not benign — Harvey said.

Given how many biopsies would therefore turn out to be negative for cancer, “short-term follow-up is a reasonable alternative to biopsy” in these women, Harvey added in a statement accompanying the study.

While the study suggests that waiting for a repeated ultrasound for six months is as safe as an immediate breast biopsy, “biopsy should be considered if the clinical exam is concerning or if the lump increases in size,” Harvey said.

Such a strategy, she added, “may reduce the number of biopsies that result in benign findings. There is also significant cost savings associated with using short-term follow-up rather than immediate biopsy.”

Human Immunodeficiency Virus (HIV) Infection,What Happens

December 4th, 2009           7 views

What Happens

There are two types of HIV:

  • HIV-1, which causes almost all the cases of AIDS worldwide
  • HIV-2, which causes an AIDS-like illness. HIV-2 infection is uncommon in the United States.

How the disease is spread

HIV is spread when blood, semen, or vaginal fluids from an infected person enter another person’s body, usually through:

  • Sexual contact. The virus may enter the body through a tear in the lining of the rectum, vagina, urethra, or mouth. Between 75% and 80% of all cases of HIV are transmitted by sexual contact.
  • Infected blood. HIV can be spread when a person:
    • Shares needles, syringes, cookers, cotton, cocaine spoons, or eyedroppers used for injecting drugs or steroids.
    • Is accidentally stuck with a needle or other sharp item that is contaminated with HIV.

It is now extremely rare in the United States for HIV to be transmitted by blood transfusions or organ transplants. Blood and organ donors are screened for risk factors. All donated blood and organs are screened for HIV.

Health care workers are no longer considered to be at high risk of exposure to HIV. Policies are in place in health facilities that require protection from accidental exposure. Workers must properly dispose of sharp objects and wear protective gloves, gowns, and eye and face protection. These measures have been effective in protecting health care workers from HIV.

Spread of HIV to babies

A woman who is infected with HIV can spread the virus to her baby during pregnancy, delivery, or breast-feeding.

  • Most children younger than 13 years who have HIV were infected with the virus by their mothers.
  • The risk of a woman spreading HIV to her baby can be greatly reduced if she is on medicine that reduces her viral load (HIV RNA) to undetectable levels during pregnancy, if she receives AZT (ZDV) before the baby is born, and if she does not breast-feed her baby. The baby should also receive treatment after it is born.

Ways HIV cannot be spread

HIV does not survive well outside the body. Therefore, HIV cannot be spread through casual contact—such as sharing drinking glasses or by casual kissing—with an infected person. HIV is not transmitted through contact with an infected person’s saliva, sweat, tears, urine, or feces, or through insect bites.

Contagious and incubation period

The incubation period—the time between when a person is first infected with HIV and when early symptoms develop—may be a few days to several weeks.

It can take as little as 2 weeks or as long as 6 months from the time you become infected with HIV for the antibodies to be detected in your blood. This is commonly called the “window period,” or seroconversion period. During the window period, you are contagious and can spread the virus to others. If you think you have been infected with HIV but you test negative for it, you should be tested again 6 months later.

After you become infected with HIV, your blood, semen, or vaginal fluids are always infectious, even if you receive treatment for the HIV infection.

Stages of HIV

Most people go through the following stages after being infected with HIV if the infection is not treated:

  • Acute retroviral syndrome, which has symptoms similar to mononucleosis. This often develops within a few days of infection, but may occur several weeks after the person is infected.
  • HIV without symptoms (asymptomatic). It may take years for HIV symptoms to develop. But even though no symptoms are present, the virus is multiplying (or making copies of itself) in the body during this time. HIV multiplies so quickly that the immune system cannot destroy the virus. After years of fighting HIV, the immune system starts to weaken.
  • HIV with symptoms (symptomatic). After your immune system starts to weaken, you are more likely to develop certain infections or illnesses, such as some types of pneumonia or cancer that are more common in people who have a weakened immune system.
  • AIDS, which occurs during the last stage of infection with HIV. If HIV goes untreated, AIDS develops in most people within 12 to 13 years after the initial infection. With treatment for HIV, the progression to AIDS may be delayed or prevented.

A small number of people who are infected with HIV are rapid progressors. They develop AIDS within a few years if they do not receive treatment. It is not known why the infection progresses faster in these people.

Nonprogressors and HIV-resistant

A few people have HIV that does not progress to more severe symptoms or disease. They are referred to as nonprogressors.

A small number of people never become infected with HIV despite years of exposure to the virus. For example, they may have repeated, unprotected sex with an infected person. These people are said to be HIV-resistant.

Recommend 8 Sleep-better foods

November 20th, 2009           0 views

NONFAT POPCORN

Pop a bag half an hour before bedtime: The carbs will induce your body to create serotonin, a neurochemical that makes you feel relaxed. Skipping the butter-fat will slow the process of boosting those feel-good chemicals, and, as mentioned above, will also slow digestion in general.
OATMEAL WITH SLICED BANANA

Sleep is inspired by the hormone melatonin, but stress or excitement can disrupt melatonin’s release. Bring your brain back down to earth by whipping up a bowl of instant oatmeal and topping it with a sliced banana, which is rich in melatonin.
1 CUP OF PLAIN YOGURT WITH 2 TABLESPOONS MIXED NUTS

Scientists in Slovakia gave people either 3 grams each of two amino acids (lysine and arginine) or a placebo and asked them to deliver a speech. Blood measurements of stress hormones revealed that the amino acid-fortified speakers were half as anxious during and after the speech as those who took the placebo. Yogurt is one of the best food sources of lysine; nuts pack tons of arginine. Because both contain alertness-inducing protein, you’re best off eating this combo a few hours before bed (or even at midday, before a big, stressful presentation at work). It’ll reduce the residual stress you feel later in the evening, meaning you won’t replay your day over and over again in your head as you try to fall asleep.
A PILE OF SESAME SEEDS
A HANDFUL OF PRETZELS
1 GLASS OF WINE
A 4-OZ GLASS OF UNSWEETENED CHERRY JUICE
RED BELL PEPPERS
Researchers at the University of Alabama fed rats 200 milligrams of vitamin C twice a day and found that it nearly stopped the secretion of cortisol, a hormone released in your body when you’re stressed. Calorie for calorie, red bell peppers give you more vitamin C than any other fruit or vegetable.

Green Tea and Mushrooms May Lower Breast-Cancer Risk

November 19th, 2009           3 views

      Women who eat large amounts of mushrooms and drink a lot of green tea may be at lower risk for developing breast cancer, a recent study reported in the International Journal of Cancer.

The research trial included more than 2,000 Chinese women, with 1,009 breast-cancer patients (aged 20-87) and an equal number of healthy women matched for age. Each woman completed a detailed dietary questionnaire citing specific foods consumed.

Do mushrooms and green tea affect breast-cancer rates?

The researchers found that the greater the mushroom consumption (both fresh and dried), the lower the breast-cancer risk. Those who ate the greatest amounts of fresh mushrooms (10 grams or more per day) were about 2/3 less likely than those who ate none at all to develop breast cancer. Subjects who ate 4 grams per day saw their breast-cancer risk fall by half.

Interestingly, the women decreased their risk even more if they also drank green tea daily. The breast-cancer risk of women who consumed both mushrooms and green tea was 11 percent, compared to 18 percent for women who didn’t consume either food. The study used green tea, which is a “younger” tea but which still has caffeine.

No proof yet

While the researchers eliminated possible confounding factors, this study does not prove that mushrooms and green tea actually reduce a woman’s chances of getting breast cancer.

Epidemiological studies, however, do show that in places where the Chinese people are still eating the traditional diet, breast-cancer rates are 4-to-5 times lower than those of most developed countries. (All bets are off if a Chinese woman has switched to eating a westernized diet.)

While this study has not nailed down a cause-and-effect relationship, it is the first to link high dietary consumption of mushrooms and green tea to reduced breast-cancer risk. In addition, those participants who ate at least 10 grams of mushrooms per day saw the greatest reductions in their risk. (See Mushrooms: The Ultimate Longevity Food.)

So eat some!

Half a cup of raw mushrooms weighs roughly 35 grams, so a little more than 1/8 cup of raw mushrooms a day (about 8 or 9 grams’ worth) might just help reduce your breast-cancer risk. Even an 8-ounce cup of raw mushrooms would add up to only 10 calories; therefore, a big helping of these tasty fungi might also help you feel fuller and lose weight. Adding green tea may be a good idea, too. (See Go Green for Your Breast Health.)

If you’re a mushroom-lover or willing to try them, here are some tips:

  • Look for mushrooms that are firm, unblemished, and free of mold or surface moisture (but not dry).
  • Store pre-packed containers of mushrooms in airtight plastic bags in the fridge, so they’ll hold on to their moisture and won’t spoil so rapidly.
  • Place loose mushrooms in a paper bag and then in your fridge.
  • Squeeze some lemon or lime juice onto raw mushrooms to help them retain their color.

New device boosts heart failure survival

November 19th, 2009           0 views

        For the first time, a miniature heart pump shows the potential to become a widely used, permanent treatment for many older people with severe heart failure. But can we afford it?
      In a study of 200 patients, the new device increased by four times the number who survived at least two years compared with an older pump that had drawbacks limiting its use, doctors reported Tuesday.

      However, the HeartMate II costs $80,000 plus $45,000 or so for the surgery and the hospital stay necessary to implant it.

      “It will allow older people who are not heart transplant patients to stay alive but at a higher cost. It’s all about who’s going to pay,” said Cleveland Clinic heart chief Dr. Steven Nissen, who had no role in the research.

        Even now, “the amount of money spent in the care of advanced heart failure patients is extraordinary,” said Dr. Robert Harrington, heart research chief at Duke University, which helped test the device. “These are societal questions — how much is too much?”

Study results were presented Tuesday at an American Heart Association conference and published by the New England Journal of Medicine.

About 5 million Americans have heart failure, which occurs when the heart weakens over time and cannot pump enough blood. Heart transplants are one solution. But few patients find a donor, and many are too old or sick for a transplant.

Left ventricular assist devices, or LVADs, can be implanted next to the heart to help it pump. However, current ones wear out too fast to be long-term solutions, and survival remains dismal — only half of patients live a year and only one-quarter live two years.

The HeartMate II, made by Thoratec Corp. of Pleasanton, Calif., is the first of a new generation of smaller pumps that push blood continuously rather than simulating a heartbeat as older pumps do. A wire from the patient’s abdomen connects the pump to equipment outside the body — a small computer and batteries that the patient wears in a belt pack or harness.

The device was approved last year for short-term use in people awaiting a transplant. The new study tested it as a permanent therapy in people with severe heart failure who were not candidates for a transplant. The study was sponsored by Thoratec, and many study leaders consult for the company or rival device makers.

While other manufacturers make similar pumps, the study was the first large test of these new-generation devices as a permanent treatment.

It enrolled 200 severely ill patients as young as 26 and as old as 81. Two-thirds got the new device. The rest received an older HeartMate pump. After two years, 46 percent of those on the new pump and 11 percent of those on the old one were alive without having suffered a stroke or a device failure.

A cost-effectiveness study has not been done, but doctors hope the new device will prove cheaper by preventing the many complications and hospitalizations these patients endure now, said Duke’s Dr. Joseph Rogers, a study co-leader.

There is a high death rate from the surgery or soon after it: 14 percent with the newer pump and 25 percent with the older one. Even so, most patients will still risk the surgery “because the alternative is worse,” and far more perish without a device, said study co-leader Dr. Mark Slaughter, heart surgery chief at the University of Louisville.

It was an easy choice for Chuck Sixour, a retired school administrator in suburban Knoxville, Tenn.

“I’m 78. My heart’s probably 90, but I feel 60, and the doctors tell me I look 60, mainly because I’ve been very active all my life,” he said.

He received the new device in August 2007 as part of the study. And now? “You name it — I do it,” he said. “I golf two or three times a week. I go shopping with my wife.”

Many older people are healthy other than having weak hearts, said Dr. Alfred Bove, a Temple University heart specialist and president of the American College of Cardiology.

“There are so many of these people that would enjoy life if we could get them out of heart failure,” he said.

Not all are old, either. Leonor Ortiz Childers, a 46-year-old lawyer in Durham, N.C., developed heart failure when she had to be treated for breast cancer while pregnant with twins. The federal Food and Drug Administration allowed her to receive a HeartMate II for emergency use a year ago.

Now, with four children under 4, the device makes it possible “to live a fairly normal life,” she said. “Every day I can hug my children. And as long as I have that, I’m a happy woman.”

U.S. sees 10 million more H1N1 vaccine doses next week

October 31st, 2009           3 views

Five drug companies are now increasing production of the vaccine for the H1N1 swine flu, and 10 million more doses are expected next week, Health and Human Services Secretary Kathleen Sebelius said on Saturday.

President Barack Obama on Friday expressed frustration about the slow pace of production of the vaccine, which has resulted in just 26.6 million doses as of Friday, far below earlier estimates of 40 million by the end of October.

Sebelius said those initial estimates were based on “overly optimistic” predictions by the five contracted vaccine makers for the U.S. market — MedImmune, a unit of AstraZeneca, Sanofi-Aventis, Australia’s CSL, GlaxoSmithKline and Novartis.

But production was now increasing and vaccine doses were being shipped seven days a week, Sebelius told CNN.

“The good news is that we have, as of yesterday, 26.6 million doses out and around the country. We are expecting another 10 million doses next week,” Sebelius said. “So the vaccine is beginning to roll in larger volumes. And it’s being distributed as quickly as it comes off the line.”

“It’s being shipped overnight. We’re getting it from producers seven days a week,” she added.

HHS initially estimated that 20 million doses would roll out every week, but the companies are currently producing only about 10 million doses a week.

The latest count shows 114 children have been killed by the virus in the United States since April, during a time when there is usually virtually no influenza, according to the U.S. Centers for Disease Control and Prevention.

CDC researchers estimated this week that as many as 5.7 million people in the United States have been infected so far, with at least 1,300 deaths. The flu has been reporting in 48 states, an unprecedented level.

David Axelrod, Obama’s senior adviser, told National Public Radio in an interview aired on Saturday that the administration “overpromised” the vaccine based on the companies’ assurances.

But he said the problem was abating every day: “We believe that that is improving on a daily basis, and we’re going to have an ample supply in very short order.”

Sebelius told CNN there was now a good mix of the nasal vaccine and the nasal mist available after earlier shortages, and the government expected to make sufficient vaccine doses available “over the next several months.”

The United States still planned to participate in an 11-nation program to donate H1N1 vaccine to developing countries, but only after the priority population in the United States had been vaccinated, Sebelius said.

“The first priority is to get the vaccine to the American people,” Sebelius said. “That’s always been the plan. It continues to be the plan.”

But she said vaccinations were also critical in developing countries and refugee camps, where hundreds of thousands of people could die as a result of the flu, Sebelius said.